Abstract
Androgen signaling is critical for proliferation of prostate cancer cells but cannot be fully inhibited by current androgen deprivation therapies. A study by Xu et al. in this issue of Cancer Cell provides insights into the complexities of androgen signaling in prostate cancer and suggests avenues to target a subset of androgen-sensitive genes.
Original language | English (US) |
---|---|
Pages (from-to) | 245-247 |
Number of pages | 3 |
Journal | Cancer cell |
Volume | 15 |
Issue number | 4 |
DOIs | |
State | Published - Apr 7 2009 |
ASJC Scopus subject areas
- Oncology
- Cell Biology
- Cancer Research